Novel Cancer Therapy: Pain Treatment Discovery (Lung, Anticancer)   Lung and Other Malignant Cancer Pain Biotherapeutics Biopharmaceuticals
Celtic Biotech Drug Discovery: Crotoxin
  • Irish Biotech Company with a focus on developing novel cancer & pain therapies

  • July 2011
    Clinical site opened for Phase Ib clinical trial in advanced cancer at Service
    d' Oncologie medicale du Pr. Oudard Hopital GEORGES POMPIDOU Paris

    17th October 2011
    A Phase Ib clinical trial safety study approved by the French Regulatory
    Authorities began today at the George Pompidou University Hospital, Paris,
    under the supervision of Assistant Professor of Oncology, Dr Jacques
    Medioni. The study intends to highlight the safety and therapeutic potential
    of Celtic Biotech's lead product CB24.
    The clinical trial is expected to be completed within 12 months.
   CONTACT US    LINK RESOURCES    HOME PAGE
Novel Cancer Therapy: Pain Treatment Discovery (Lung, Anticancer)
Copyright © 2005 Celtic Biotech, Ltd.: Novel Cancer Therapy & Pain Treatment Drug Discovery
Email Us   Top of Page